Company Ekso Bionics Holdings, Inc.
Equities
EKSO
US2826443010
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | +6.62% | +15.08% | -42.00% |
Apr. 29 | Transcript : Ekso Bionics Holdings, Inc., Q1 2024 Earnings Call, Apr 29, 2024 | |
Apr. 29 | Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 71
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
EksoHealth
96.8
%
| 12 | 91.6 % | 18 | 96.8 % | +49.64% |
EksoWorks
3.2
%
| 1 | 8.4 % | 1 | 3.2 % | -46.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
68.4
%
| 7 | 50.8 % | 13 | 68.4 % | +90.64% |
Other EMEA
10.3
%
| 3 | 22.0 % | 2 | 10.3 % | -33.86% |
APAC
8.3
%
| 2 | 17.5 % | 2 | 8.3 % | -32.61% |
Poland
7.7
%
| - | - | 1 | 7.7 % | - |
Other Americas
2.7
%
| 0 | 2.0 % | 0 | 2.7 % | +96.43% |
Germany
2.6
%
| 1 | 7.8 % | 0 | 2.6 % | -52.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 21-03-31 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 17-04-30 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
David Carey
IRC | Investor Relations Contact | - | - |
Ann Cookson
HRO | Human Resources Officer | - | 22-03-31 |
Andy McGuigan
PRN | Corporate Officer/Principal | - | 21-12-31 |
Rino Bevis
PRN | Corporate Officer/Principal | - | 19-12-31 |
Anthony Pratt
SAM | Sales & Marketing | - | 19-08-31 |
Rachael Adams
SAM | Sales & Marketing | - | - |
Stephan Aderhold
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 57 | 21-12-24 |
Rhonda Wallen
BRD | Director/Board Member | 57 | 20-12-28 |
Mary Cloyd
BRD | Director/Board Member | 69 | 20-12-28 |
Charles Li
BRD | Director/Board Member | 39 | 18-03-10 |
Scott Davis
CEO | Chief Executive Officer | 54 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,174,426 | 16,500,566 ( 90.79 %) | 0 | 90.79 % |
Company contact information
Ekso Bionics Holdings, Inc.
101 Glacier Point Suite A
94901, San Rafael
+510 984 1761
http://www.eksobionics.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.00% | 24.72M | |
+12.50% | 229B | |
+14.52% | 195B | |
+17.51% | 142B | |
+28.96% | 109B | |
+3.27% | 64.85B | |
+18.16% | 54.33B | |
+7.63% | 52.09B | |
+10.95% | 45.15B | |
+5.10% | 37.39B |
- Stock Market
- Equities
- EKSO Stock
- Company Ekso Bionics Holdings, Inc.